Literature DB >> 7444937

A sibling case of hyperphenylalaninemia due to a deficiency of dihydropteridine reductase: biochemical and pathological findings.

K Tada, K Narisawa, N Arai, Y Ogasawara, S Ishizawa.   

Abstract

Three siblings with hyperphenylalaninemia were described, who showed convulsions and severe mental retardation despite dietary control of blood phenylalanine. The cultured skin fibroblasts from two patients revealed a markedly low activity of dihydropteridine reductase. These patients showed low levels of serum folate and of 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid. The postmortem examination on one of these siblings exhibited the dysmyelination in the cerebrum and spongy lesions of the white matter in the cerebellum, pons, medulla oblongata and spinal cord. Many minute foci of calcification were found in the cerebrum, which were located in the perivascular space of the small blood vessels. Such calcification was observed on CT scanning of the brain in the other two living siblings as well.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7444937     DOI: 10.1620/tjem.132.123

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  10 in total

1.  Cranial computerized tomography in dihydropteridine reductase deficiency.

Authors:  R Longhi; R Valsasina; C Buttè; S Paccanelli; E Riva; M Giovannini
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

2.  Molecular analysis of dihydropteridine reductase deficiency and restoration of the enzyme activity by gene transfer.

Authors:  H Mikami; Y Matsubara; K Hayasaka; K Narisawa; M Obinata; A Watanabe; K Haginoya; S Miyabayashi; K Tada; H H Dahl
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Hyperphenylalaninemia due to impaired dihydrobiopterin biosynthesis.

Authors:  T Tanaka; K Aihara; K Iwai; M Kohashi; K Tomita; K Narisawa; N Arai; H Yoshida; T Usui
Journal:  Eur J Pediatr       Date:  1981-07       Impact factor: 3.183

4.  Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin.

Authors:  R R McInnes; S Kaufman; J J Warsh; G R Van Loon; S Milstien; G Kapatos; S Soldin; P Walsh; D MacGregor; W B Hanley
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

5.  Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man.

Authors:  A Niederwieser; H C Curtius; M Wang; D Leupold
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

Review 6.  Pteridines and mono-amines: relevance to neurological damage.

Authors:  I Smith; D W Howells; K Hyland
Journal:  Postgrad Med J       Date:  1986-02       Impact factor: 2.401

7.  CT findings in a case of deficiency of 3-hydroxy-3-methylglutaryl-CoA-lyase.

Authors:  G Lisson; D Leupold; D Bechinger; C Wallesch
Journal:  Neuroradiology       Date:  1981       Impact factor: 2.804

8.  Basal ganglion calcification in hyperphenylalaninemia due to deficiency of dihydropteridine reductase.

Authors:  H Schmidt; K Ullrich; R Korinthenberg; P E Peters
Journal:  Pediatr Radiol       Date:  1988

9.  Clinical role of pteridine therapy in tetrahydrobiopterin deficiency.

Authors:  I Smith; K Hyland; B Kendall
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

10.  Cranial MR spectroscopy of tetrahydrobiopterin deficiency.

Authors:  Yin-Hsiu Chien; Shiin-Feng Peng; Tso-Ren Wang; Wuh-Liang Hwu
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.